OpenEvidence raised $210 million in a Series B funding round co-led by Google Ventures and Kleiner Perkins, valuing the company at $3.5 billion and bringing total funding to over $300 million. The company will use the funds to expand its strategic content partnerships and further develop its physician-focused clinical decision support platform.